snsinsider 님의 블로그

The Molecular Imaging Market was valued at USD 8.47 billion in 2023 and is projected to reach USD 12.5 billion by 2032, expanding at a CAGR of 4.5% during the forecast period 2024-2032. The growing prevalence of chronic diseases, particularly cancer and neurological disorders, is driving demand for molecular imaging solutions. Technological advancements in imaging modalities such as positron emi..

The Chromatography Instruments Market was valued at USD 9.47 billion in 2023 and is projected to reach USD 14.90 billion by 2032, registering a CAGR of 5.19% over the forecast period from 2024 to 2032. The market’s growth is fueled by increasing applications of chromatography in pharmaceutical, biotechnology, food safety, environmental testing, and clinical research. The growing need for precise..

The Genomics Biomarker Market was valued at USD 4.84 billion in 2023 and is projected to reach USD 10.39 billion by 2032, registering a CAGR of 8.89% over the forecast period from 2024 to 2032. The market's expansion is fueled by the rising prevalence of chronic diseases, increasing adoption of personalized medicine, and advancements in genomic sequencing technologies. As healthcare systems worl..

The Next-generation Sequencing (NGS) Data Analysis Market was valued at USD 791.07 million in 2023 and is projected to reach USD 4.21 billion by 2032, growing at an exceptional CAGR of 19.93% from 2024 to 2032. The exponential rise in genomic data, the growing application of sequencing technologies in personalized medicine, and continuous advancements in bioinformatics tools are key drivers behi..

The Single-Cell Sequencing Market was valued at USD 2,109.8 million in 2023 and is projected to reach USD 7,420.8 million by 2032, registering a CAGR of 15% from 2024 to 2032. The rapid growth of this market is fueled by increasing adoption of single-cell sequencing technologies in biomedical research, precision medicine, and drug discovery. As scientists continue to explore cellular heterogenei..

The Heart Valve Devices Market was valued at USD 11.7 billion in 2023 and is projected to reach USD 33.2 billion by 2032, growing at a CAGR of 12.3% over the forecast period from 2024 to 2032. This remarkable growth is attributed to the increasing prevalence of cardiovascular diseases (CVDs), advancements in transcatheter heart valve replacement (TAVR) technology, and rising demand for minimally..

The Cardiac Biomarker Testing Market was valued at USD 4.53 billion in 2023 and is projected to reach USD 10.21 billion by 2032, registering a CAGR of 9.47% over the forecast period from 2024 to 2032. The growing burden of cardiovascular diseases (CVDs), the increasing adoption of point-of-care (POC) testing, and technological advancements in biomarker detection are key factors fueling market gr..